NeoPharm CO., LTD. (KOSDAQ:092730)

Market Cap	270.44B
Revenue (ttm)	123.77B
Net Income (ttm)	25.27B
Shares Out	15.64M
EPS (ttm)	1,615.84
PE Ratio	10.70
Forward PE	10.92
Dividend	600.00 (3.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	88,793
Average Volume	198,779
Open	17,130
Previous Close	17,290
Day's Range	16,690 - 17,240
52-Week Range	10,700 - 22,650
Beta	0.61
RSI	39.33
Earnings Date	Nov 14, 2025

About NeoPharm CO., LTD.

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, So...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2000
• Employees: 82
• Stock Exchange: KOSDAQ
• Ticker Symbol: 092730

Financial Performance

In 2024, NeoPharm CO., LTD.'s revenue was 119.01 billion, an increase of 22.56% compared to the previous year's 97.10 billion. Earnings were 23.06 billion, a decrease of -0.64%.